LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global coronary stents market is projected to grow to USD 11.94 billion by 2021, at a CAGR of close to 6% over the forecast period.
This research report titled ‘Global Coronary Stents Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.
| Coronary stents or cardiac stents are small, expandable, tube-shaped devices made of stainless steel, which are placed in the coronary artery to supply blood to the heart and keep it open during the treatment of coronary artery disease (CAD). Currently, many manufacturers are outsourcing research to clinical research organizations, which is indirectly boosting the growth of the coronary stents market. |
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Based on the product type, the report categorizes the global coronary stents market into the following segments:
- Drug-eluting stents (DES)
- Bare-metal stents (BMS)
- Bioresorbable stents
Drug-eluting stents (DES)
“Drug-eluting stents occupied over 70% of the global coronary stents market in 2016, and are expected to continue its dominance through the forecast period,” says Srinivas Sashidhar, a lead analyst at Technavio for cardiovascular devices research.
DES are coated with drugs like paclitaxel, everolimus, and antiproliferative drugs and are used for the prevention of renarrowing, reblocking, or inflammation of the artery after stent implantation. The key vendors for DES are Abbott Laboratories that manufactures XIENCE PRIME, Boston Scientific that manufactures PROMUS Element, and Medtronic that manufactures Resolute Integrity.
Bare-metal stents (BMS)
Bare metal stents are mesh tubes made of thin metal wires of stainless steel, cobalt-chromium, platinum, nickel, or titanium. These stents require one month of dual antiplatelet therapy for a month after stent implantation. Cobalt alloy and platinum-chromium stents are the most widely adopted types of BMS, as they are strong, stable, corrosion resistant, and biocompatible. The key companies that manufacture BMS are Abbott Laboratories, Boston Scientific, Medtronic, and medium-sized or small companies such as Biosensors International Group.
Bioresorbable stents
“The bioresorbable stent is a drug-eluting non-metallic, non-permanent stent that is absorbed by the body in due time and disappears after 12-24 months of implantation. These stents are becoming increasingly popular and are expected to grow at an explosive CAGR of nearly 25%,” says Srinivas.
The key market enablers for the bioresorbable stent include reduced risk of late stent thrombosis, restoration of the normal function of blood vessels, and fast healing. Though the cost of bioresorbable stents is high, its clinical efficacy drives both physicians and individuals to adopt these stents.
The top vendors highlighted by Technavio’s research analysts in this report are:
- Abbott Laboratories
- Boston Scientific
- Medtronic
Browse Related Reports:
- Global Hemodialysis Catheter Market 2017-2021
- Global Radiofrequency Ablation Market 2017-2021
- Global Implantable Ports Market 2017-2021
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like central nervous system, in-vitro diagnostics, and infectious and rare diseases. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
